Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure

Background—Heart failure (HF) is the leading cause for hospital readmission. Hospice care may help palliate HF symptoms but its association with 30-day all-cause readmission remains unknown. Methods and Results—Of the 8032 Medicare beneficiaries hospitalized for HF in 106 Alabama hospitals (1998–2001), 182 (2%) received discharge hospice referrals. Of the 7850 patients not receiving hospice referrals, 1608 (20%) died within 6 months post discharge (the hospice-eligible group). Propensity scores for hospice referral were estimated for each of the 1790 (182+1608) patients and were used to match 179 hospice-referral patients with 179 hospice-eligible patients who were balanced on 28 baseline characteristics (mean age, 79 years; 58% women; 18% non-white). Overall, 22% (1742/8032) died in 6 months, of whom 8% (134/1742) received hospice referrals. Among the 358 matched patients, 30-day all-cause readmission occurred in 5% and 41% of hospice-referral and hospice-eligible patients, respectively (hazard ratio associated with hospice referral, 0.12; 95% confidence interval, 0.06–0.24). Hazard ratios (95% confidence intervals) for 30-day all-cause readmission associated with hospice referral among the 126 patients who died and 232 patients who survived 30-day post discharge were 0.03 (0.04–0.21) and 0.17 (0.08–0.36), respectively. Although 30-day mortality was higher in the hospice referral group (43% versus 27%), it was similar at 90 days (64% versus 67% among hospice-eligible patients). Conclusions—A discharge hospice referral was associated with lower 30-day all-cause readmission among hospitalized patients with HF. However, most patients with HF who died within 6 months of hospital discharge did not receive a discharge hospice referral.

[1]  C. Morgan,et al.  Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure. , 2015, The American journal of medicine.

[2]  Maureen A. Smith,et al.  Hospice Enrollment, Local Hospice Utilization Patterns, and Rehospitalization in Medicare Patients. , 2015, Journal of palliative medicine.

[3]  J. Butler,et al.  Advance directives among hospitalized patients with heart failure. , 2015, JACC. Heart failure.

[4]  GozaloPedro,et al.  A National Study of Live Discharges from Hospice , 2014 .

[5]  R. Gramling,et al.  Palliative care referral among patients hospitalized with advanced heart failure. , 2014, Journal of palliative medicine.

[6]  C. Morgan,et al.  Lack of Association Between Spironolactone Use and 30-Day All-Cause Readmission In Hospitalized Medicare Beneficiaries With Systolic Heart Failure Eligible for Spironolactone Therapy , 2014 .

[7]  K. Lohr,et al.  Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure , 2014, Annals of Internal Medicine.

[8]  C. Morgan,et al.  DISCHARGE INITIATION OF ACE INHIBITORS OR ARBS IS ASSOCIATED WITH SIGNIFICANTLY LOWER 30-DAY ALL-CAUSE READMISSION IN HOSPITALIZED OLDER PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION , 2014 .

[9]  J. Fleg,et al.  Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure. , 2014, The American journal of medicine.

[10]  J. Fleg,et al.  Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. , 2014, The American journal of medicine.

[11]  J. Fleg,et al.  Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. , 2013, The American journal of medicine.

[12]  R. Kheirbek,et al.  Trajectory of illness for patients with congestive heart failure. , 2013, Journal of palliative medicine.

[13]  M. Gheorghiade,et al.  Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction. , 2013, The American journal of medicine.

[14]  M. Konstam Heart failure in the lifetime of Musca domestica (the common housefly). , 2013, JACC. Heart failure.

[15]  Jeremiah R. Brown,et al.  Palliative care consultations for heart failure patients: how many, when, and why? , 2013, Journal of cardiac failure.

[16]  M. Rich,et al.  Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. , 2013, The American journal of medicine.

[17]  R. Allman,et al.  Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: findings from the Alabama Heart Failure Project. , 2012, International journal of cardiology.

[18]  S. Enguídanos,et al.  30-day readmissions among seriously ill older adults. , 2012, Journal of palliative medicine.

[19]  M. Rich,et al.  Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease. , 2012, The American journal of medicine.

[20]  K. Schulman,et al.  Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. , 2011, Archives of internal medicine.

[21]  Roger B. Davis,et al.  Association of hospice agency profit status with patient diagnosis, location of care, and length of stay. , 2011, JAMA.

[22]  J. Rassen,et al.  The comparative safety of analgesics in older adults with arthritis. , 2010, Archives of internal medicine.

[23]  Nancy M Albert,et al.  HFSA 2010 Comprehensive Heart Failure Practice Guideline. , 2010, Journal of cardiac failure.

[24]  R. McKelvie,et al.  Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial , 2010, Circulation.

[25]  P. Brubaker,et al.  Circ Heart Fail , 2010 .

[26]  D. Meier,et al.  Palliative Care in the Treatment of Advanced Heart Failure , 2009, Circulation.

[27]  Sarah J. Goodlin,et al.  Palliative care in congestive heart failure. , 2009, Journal of the American College of Cardiology.

[28]  Richard E. Rohr,et al.  Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.

[29]  Mark V. Williams,et al.  Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.

[30]  W. Peacock,et al.  Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis , 2008, Emergency Medicine Journal.

[31]  S. Payne,et al.  Predicting mortality among a general practice-based sample of older people with heart failure , 2008, Chronic illness.

[32]  Nancy M Albert,et al.  Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. , 2007, Journal of the American College of Cardiology.

[33]  M. Gheorghiade,et al.  Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. , 2006, European heart journal.

[34]  M. Rich,et al.  Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. , 2006, European heart journal.

[35]  D. Rubin Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation , 2001, Health Services and Outcomes Research Methodology.

[36]  R. Califf,et al.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.

[37]  Paul R. Rosenbaum,et al.  Sensitivity to Hidden Bias , 2002 .

[38]  Roger B. Davis,et al.  The Last Six Months of Life for Patients with Congestive Heart Failure , 2000, Journal of the American Geriatrics Society.

[39]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[40]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .